AAAAAA
Results:
1-11
|
Results: 11
Authors:
Losman, B
Bolmstedt, A
Schonning, K
Bjorndal, A
Westin, C
Fenyo, EM
Olofsson, S
Citation: B. Losman et al., Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region, AIDS RES H, 17(11), 2001, pp. 1067-1076
Authors:
Tscherning-Casper, C
Vodros, D
Menu, E
Aperia, K
Fredriksson, R
Dolcini, G
Chaouat, G
Barre-Sinoussi, F
Albert, J
Fenyo, EM
Citation: C. Tscherning-casper et al., Coreceptor usage of HIV-1 isolates representing different genetic subtypesobtained from pregnant Cameroonian women, J ACQ IMM D, 24(1), 2000, pp. 1-9
Authors:
Tscherning-Casper, C
Dolcini, G
Mauclere, P
Fenyo, EM
Barre-Sinoussi, F
Albert, J
Menu, E
Citation: C. Tscherning-casper et al., Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon, AIDS RES H, 16(13), 2000, pp. 1313-1318
Authors:
Lallos, LB
Cecilia, D
Fenyo, EM
Laal, S
Zolla-Pazner, S
Citation: Lb. Lallos et al., HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) classII in the virion envelope, AIDS, 14(11), 2000, pp. 1523-1531
Authors:
Lawoko, A
Johansson, B
Ljunggren, J
Fries, A
Fredriksson, R
Georgievska, L
Malmvall, B
Pipkorn, R
Fenyo, EM
Blomberg, J
Citation: A. Lawoko et al., Structural prerequisites for intersubtype B and D antigenicity of the third variable envelope region (V3) of human immunodeficiency virus type 1, J INFEC DIS, 182(1), 2000, pp. 49-58
Authors:
Jansson, M
Backstrom, E
Bjorndal, A
Holmberg, V
Rossi, P
Fenyo, EM
Popovic, M
Albert, J
Wigzell, H
Citation: M. Jansson et al., Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS, J HUMAN VIR, 2(6), 1999, pp. 325-338
Authors:
Bjorndal, A
Sonnerborg, A
Tscherning, C
Albert, J
Fenyo, EM
Citation: A. Bjorndal et al., Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients, AIDS RES H, 15(7), 1999, pp. 647-653
Authors:
Flore, JR
Buccoliero, G
Pezzotti, P
Rezza, G
Saracino, A
Pastore, G
Fenyo, EM
Angarano, G
Citation: Jr. Flore et al., HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner, AIDS, 13(13), 1999, pp. 1801-1802
Authors:
Lawoko, AL
Johansson, B
Hjalmarsson, S
Christensson, B
Ljungberg, B
Al-Khalili, L
Sjolund, M
Pipkorn, R
Fenyo, EM
Blomberg, J
Citation: Al. Lawoko et al., Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera, J MED VIROL, 59(2), 1999, pp. 169-179
Authors:
Morner, A
Bjorndal, A
Albert, J
Kewalramani, VN
Littman, DR
Inoue, R
Thorstensson, R
Fenyo, EM
Bjorling, E
Citation: A. Morner et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage, J VIROLOGY, 73(3), 1999, pp. 2343-2349
Authors:
Tscherning-Casper, C
Papadogiannakis, N
Anvret, M
Stolpe, L
Lindgren, S
Bohlin, AB
Albert, J
Fenyo, EM
Citation: C. Tscherning-casper et al., The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy, J VIROLOGY, 73(11), 1999, pp. 9673-9678
Risultati:
1-11
|